Citation Impact
Citing Papers
Precise and Heritable Genome Editing in Evolutionarily Diverse Nematodes Using TALENs and CRISPR/Cas9 to Engineer Insertions and Deletions
2013 StandoutNobel
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
2013 StandoutScience
Rationally engineered Cas9 nucleases with improved specificity
2015 StandoutScience
Machine learning predicts new anti-CRISPR proteins
2020 StandoutNobel
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
2007 StandoutScience
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
2015 StandoutNatureNobel
Management of hepatitis B
2007
CRISPR/Cas9: A powerful tool for crop genome editing
2016
Chronic hepatitis B in children after e antigen seroclearance: Final report of a 29-year longitudinal study
2006
A cell-free platform for the prenylation of natural products and application to cannabinoid production
2019 StandoutNobel
Optical control of mammalian endogenous transcription and epigenetic states
2013 Nature
Cell-Penetrating Peptide-Mediated Delivery of TALEN Proteins via Bioconjugation for Genome Engineering
2014
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
2016 StandoutNature
A guide to genome engineering with programmable nucleases
2014 Standout
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
2015 Standout
High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects
2016 StandoutNature
Surveillance for Hepatocellular Carcinoma and Early Diagnosis
2007
Risk and Predictors of Mortality Associated With Chronic Hepatitis B Infection
2007
Gastrointestinal stromal tumour
2007
Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA
2014 Standout
Genome-Editing Technologies: Principles and Applications
2016
Hepatitis B Virus Infection
2008
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
2014 StandoutNature
Targeted Genome Editing in Human Cells Using CRISPR/Cas Nucleases and Truncated Guide RNAs
2014
Programmable RNA Tracking in Live Cells with CRISPR/Cas9
2016 StandoutNobel
Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years
2007
Cannabis sativa: The Plant of the Thousand and One Molecules
2016
Hepatocellular carcinoma
2012 Standout
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
2013 Standout
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
2014 Standout
Hepatitis B virus DNA prediction rules for hepatitis B e antigen–negative chronic hepatitis B
2007
Enabling functional genomics with genome engineering
2015
Hepatitis B virus infection
2009 Standout
Natural history of chronic HBV infection: A cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project)
2005
Virus-mediated gene delivery for human gene therapy
2012
Easy quantitative assessment of genome editing by sequence trace decomposition
2014 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Single-Stranded DNA Cleavage by Divergent CRISPR-Cas9 Enzymes
2015 StandoutNobel
Drug Insight: gastrointestinal stromal tumors (GIST)—the solid tumor model for cancer-specific treatment
2008
Improved Cell-Penetrating Zinc-Finger Nuclease Proteins for Precision Genome Engineering
2015
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
2004 Standout
Long-Term Stability and Safety of Transgenic Cultured Epidermal Stem Cells in Gene Therapy of Junctional Epidermolysis Bullosa
2013
CRISPR-Cas systems for editing, regulating and targeting genomes
2014 Standout
Development and Applications of CRISPR-Cas9 for Genome Engineering
2014 Standout
Conformational control of DNA target cleavage by CRISPR–Cas9
2015 StandoutNatureNobel
Applications of CRISPR technologies in research and beyond
2016 StandoutNobel
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
2015 StandoutNobel
A thermostable Cas9 with increased lifetime in human plasma
2017 StandoutNobel
Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus
2013
Biology and Applications of CRISPR Systems: Harnessing Nature’s Toolbox for Genome Engineering
2016 StandoutNobel
Genome Editing in Human Stem Cells
2014
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
2016 Standout
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
Alpharetroviral self-inactivating vectors produced by a superinfection-resistant stable packaging cell line allow genetic modification of primary human T lymphocytes
2016 StandoutNobel
Hepatocellular Carcinoma
2011 Standout
Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes
2017 StandoutNobel
Targeting Human MicroRNA Genes Using Engineered Tal-Effector Nucleases (TALENs)
2013
Beyond the Antigen Receptor: Editing the Genome of T-Cells for Cancer Adoptive Cellular Therapies
2013
The Human Condition—A Molecular Approach
2014 StandoutNobel
Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors
2015
Efficient delivery of nuclease proteins for genome editing in human stem cells and primary cells
2015
The cancer genome
2009 StandoutNature
Genome-editing Technologies for Gene and Cell Therapy
2016
Delivery and Specificity of CRISPR/Cas9 Genome Editing Technologies for Human Gene Therapy
2015
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy
2023 StandoutNobel
High‐throughput screens in mammalian cells using the CRISPR‐Cas9 system
2015
Pivoting the Plant Immune System from Dissection to Deployment
2013 StandoutScience
Advances in skin grafting and treatment of cutaneous wounds
2014 StandoutScience
CRISPR-Cas: New Tools for Genetic Manipulations from Bacterial Immunity Systems
2015
Genomes in Focus: Development and Applications of CRISPR‐Cas9 Imaging Technologies
2017 StandoutNobel
Unrevealing the natural course of the so-called “inactive HBsAg or HBV carrier state”
2007
The new frontier of genome engineering with CRISPR-Cas9
2014 StandoutScienceNobel
Imaging Specific Genomic DNA in Living Cells
2016
Optimization of scarless human stem cell genome editing
2013
Rational design of a split-Cas9 enzyme complex
2015 StandoutNobel
Progressive engineering of a homing endonuclease genome editing reagent for the murine X-linked immunodeficiency locus
2014 StandoutNobel
Chimeric Antigen Receptor Therapy
2018 Standout
megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineering
2013 StandoutNobel
Viral Vectors for Gene Therapy: Translational and Clinical Outlook
2015
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors
2007
Genome Editing: A New Approach to Human Therapeutics
2015
Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery
2017 StandoutNobel
Hepatitis B Virus Replication and Liver Disease Progression: The Impact of Antiviral Therapy
2006
Genome-Wide Analysis of Alpharetroviral Integration in Human Hematopoietic Stem/Progenitor Cells
2014
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel
Works of Francesca Miselli being referenced
Targeted Gene Addition in Human Epithelial Stem Cells by Zinc-finger Nuclease-mediated Homologous Recombination
2013
Natural history of chronic HBV carriers in northern Italy: Morbidity and mortality after 30 years
2004
Functional analyses and molecular modeling of two c-Kit mutations responsible for imatinib secondary resistance in GIST patients
2006
Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells
2012
Time course of cannabinoid accumulation and chemotype development during the growth of Cannabis sativa L
2007
High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors
2010